BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15200054)

  • 1. Loop domain peptides from the SOS ras-guanine nucleotide exchange protein, identified from molecular dynamics calculations, strongly inhibit ras signaling.
    Chie L; Friedman FK; Duncan T; Chen JM; Chung D; Pincus M
    Protein J; 2004 Apr; 23(3):229-34. PubMed ID: 15200054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity of inhibition of ras-p21 signal transduction by peptides from GTPase activating protein (GAP) and the son-of sevenless (SOS) ras-specific guanine nucleotide exchange protein.
    Chie L; Chung D; Pincus MR
    Protein J; 2005 May; 24(4):253-8. PubMed ID: 16283548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of molecular dynamics averaged structures for complexes of normal and oncogenic ras-p21 with SOS nucleotide exchange protein, containing computed conformations for three crystallographically undefined domains, suggests a potential role of these domains in ras signaling.
    Duncan T; Chen JM; Friedman FK; Hyde M; Chie L; Pincus MR
    Protein J; 2004 Apr; 23(3):217-28. PubMed ID: 15200053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of oncogenic and activated wild-type ras-p21 protein-induced oocyte maturation by peptides from the guanine-nucleotide exchange protein, SOS, identified from molecular dynamics calculations. Selective inhibition of oncogenic ras-p21.
    Chie L; Chen JM; Friedman FK; Chung DL; Amar S; Michl J; Yamaizumi Z; Brandt-Rauf PW; Pincus MR
    J Protein Chem; 1999 Nov; 18(8):875-9. PubMed ID: 10839624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular dynamics analysis of the structures of ras-guanine nucleotide exchange protein (SOS) bound to wild-type and oncogenic ras-p21. Identification of effector domains of SOS.
    Chen JM; Friedman FK; Hyde MJ; Monaco R; Pincus MR
    J Protein Chem; 1999 Nov; 18(8):867-74. PubMed ID: 10839623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of new anti-cancer peptides from conformational energy analysis of the oncogenic ras-p21 protein and its complexes with target proteins.
    Pincus MR
    Front Biosci; 2004 Sep; 9():3486-509. PubMed ID: 15353372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the predicted structures of loops in the ras-SOS protein bound to a single ras-p21 protein with the crystallographically determined structures in SOS bound to two ras-p21 proteins.
    Smith S; Hyde M; Pincus MR
    Protein J; 2005 Aug; 24(6):391-8. PubMed ID: 16323045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of ras-induced oocyte maturation by peptides from ras-p21 and GTPase activating protein (GAP) identified as being effector domains from molecular dynamics calculations.
    Friedman FK; Chie L; Chung D; Robinson R; Brandt-Rauf P; Yamaizumi Z; Pincus MR
    J Protein Chem; 2002 Jul; 21(5):361-6. PubMed ID: 12206510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural analysis of autoinhibition in the Ras activator Son of sevenless.
    Sondermann H; Soisson SM; Boykevisch S; Yang SS; Bar-Sagi D; Kuriyan J
    Cell; 2004 Oct; 119(3):393-405. PubMed ID: 15507210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of Ras-SOS Interactions.
    Lu S; Jang H; Zhang J; Nussinov R
    ChemMedChem; 2016 Apr; 11(8):814-21. PubMed ID: 26630662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the average structures, from molecular dynamics, of complexes of GTPase activating protein (GAP) with oncogenic and wild-type ras-p21: identification of potential effector domains.
    Chen JM; Friedman FK; Brandt-Rauf PW; Pincus MR; Chie L
    J Protein Chem; 2002 Jul; 21(5):349-59. PubMed ID: 12206509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the site of inhibition of oncogenic ras-p21-induced signal transduction by a peptide from a ras effector domain.
    Chie L; Chen JM; Friedman FK; Chung DL; Amar S; Michl J; Yamaizumi Z; Brandt-Rauf PW; Pincus MR
    J Protein Chem; 1999 Nov; 18(8):881-4. PubMed ID: 10839625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in flexibility underlie functional differences in the Ras activators son of sevenless and Ras guanine nucleotide releasing factor 1.
    Freedman TS; Sondermann H; Kuchment O; Friedland GD; Kortemme T; Kuriyan J
    Structure; 2009 Jan; 17(1):41-53. PubMed ID: 19141281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular origin and functional consequences of digital signaling and hysteresis during Ras activation in lymphocytes.
    Chakraborty AK; Das J; Zikherman J; Yang M; Govern CC; Ho M; Weiss A; Roose J
    Sci Signal; 2009 Apr; 2(66):pt2. PubMed ID: 19366993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An orthosteric inhibitor of the RAS-SOS interaction.
    Nickerson S; Joy ST; Arora PS; Bar-Sagi D
    Enzymes; 2013; 34 Pt. B():25-39. PubMed ID: 25034099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural evidence for feedback activation by Ras.GTP of the Ras-specific nucleotide exchange factor SOS.
    Margarit SM; Sondermann H; Hall BE; Nagar B; Hoelz A; Pirruccello M; Bar-Sagi D; Kuriyan J
    Cell; 2003 Mar; 112(5):685-95. PubMed ID: 12628188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unusual interplay of two types of Ras activators, RasGRP and SOS, establishes sensitive and robust Ras activation in lymphocytes.
    Roose JP; Mollenauer M; Ho M; Kurosaki T; Weiss A
    Mol Cell Biol; 2007 Apr; 27(7):2732-45. PubMed ID: 17283063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular assemblies of the catalytic domain of SOS with KRas and oncogenic mutants.
    Moghadamchargari Z; Shirzadeh M; Liu C; Schrecke S; Packianathan C; Russell DH; Zhao M; Laganowsky A
    Proc Natl Acad Sci U S A; 2021 Mar; 118(12):. PubMed ID: 33723061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in patterns of activation of MAP kinases induced by oncogenic ras-p21 and insulin in oocytes.
    Ranginwale M; Smith S; Flom J; Chie L; Kanovsky M; Chung D; Friedman FK; Robinson RC; Brandt-Rauf PW; Yamaizumi Z; Michl J; Pincus MR
    Exp Cell Res; 2001 Sep; 269(1):162-9. PubMed ID: 11525649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A protein methyl transferase, PRMT5, selectively blocks oncogenic ras-p21 mitogenic signal transduction.
    Chie L; Cook JR; Chung D; Hoffmann R; Yang Z; Kim Y; Pestka S; Pincus MR
    Ann Clin Lab Sci; 2003; 33(2):200-7. PubMed ID: 12817625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.